ISPO

Lymphoma / Leukemia

Bone marrow transplantation in patients with chronic lymphocytic leukemia: minimal disease status using PCR amplification of igh correlates with clinical outcome

D Provan MRCP, C Zwicky MD, D Neuberg, A Maddocks, P Corradini MD, R Soiffer MD, J Ritz MD, LM Nadler MD, JG Gribben MD

The role of platelet derived growth factor (PDGF) in the pathogenesis of myelofibrosis in chronic myelogenous leukemias (CML)

A Kimura MD, O Katoh MD, H Hyodo MD

Proliferation and clonal growth of human primary leukemia cells is stimulated by FLT3 ligand through the binding to specific thyrosine kinase receptors and their phosphorylation

W Piacibello MD, F Sanavio, A Stacchini PhD, MF Brizzi MD, L Pegoraro MD, M Aglietta MD

P210 Bcr-Abl interacts with the interleukin-3 beta(C) subunit and constitutively induces tyrosine phosphorylation of Jak2

J Wilson-RawIs, S Xie, J Liu, P Laneuville, RB Arlinghaus

Importance of 5-HT transport and 5-HT1a receptors in the growth of human leukemia cells

N Khan PhD DSc, P Deschaux PhD

Diagnostic value of the peripheral blood mononuclear cell (PBMC) analysis by a simple investigation panel

K Fazekas MD, L Sreter MD DSC, B Molnar MD PhD, I Csuka DSC, G Banfalvi DSC

Multiparameter diagnosis and evaluation of prognostic factors in primary acute myeloid leukemia

G Meckenstock, A Heyll, B Hildebrandt, U Germing, C Aul, A Wehmeier, J Zahner, W Schneider

New immunotherapy against adult t cell leukemia (ATL) by using dendbitic cells as an adjuvant

M Makino MD PhD, A Tanaka MD, T Takamoto MD PhD, M Baba MD PhD, S Sonoda MD DMS

Relationship between DNA content, nuclear volume and phenotype in childhood leukemia

LM Ball MB BS MRCP MRCPath, C Lannon BSc , K Laybolt RT, D van Velzen MD PhD

Type d retroviral-specific sequences in peripheral blood lymphocytes of children with burkitt s-type lymphosarcoma and their parents

J Kzhyshkowska, V Kurmashow MD PhD, A Kiselev MD PhD, G Gordina MD PhD, N Portjanko MD PhD, K Ilyin MD PhD

Impaired signaling of IL-6-type cytokines in unresponsive myeloid leukemia cells is caused by different defects in the Jak/Stat signaling pathway

R Piekorz, R Rinke, F Gouilleux PhD, B Groner PhD, G Fey PhD, G Hocke PhD

A distinct membrane antigenic phenotype identifiers blasts from myelold blastic phase of chronic myeloid leukemia

EM Schiavone MD, C Lo Pardo MD, C Vacca MD, P Bontempo MD, E Nola MD, L Del Vecchio MD

Molecular diagnosis of the philadelphia chromosome in acute lymphoblastic leukemia (ALL)

D Mininni PhD, G Specchia MD, A Pannunzio PhD, A Mestice PhD, R Contino PhD, G Palumbo MD, D Pastore MD, V Liso MD

Successful treatment of accelerated and blastic phase of chronic myeloid leukemia (CML) with a combination of high-dose interferon alpha and hydroxyurea

U Jehn MD, V Heinemann MD

Level of immunostimulation induced by IL-2 is a critical point in the cancer therapy

E Capelli PhD, R Nano PhD, S Barni PhD, M Civallero PhD, P Cremaschi MD

Induction of anti-tumor immunity in a murine model of B cell leukemia (updated)

S Morecki PhD, Y Gelfand Msc, T Pugatsch PhD, S Slavin MD,

Comparison between two strategies of amplification of IGH gene VDJ rearrangement in multiple myeloma

E LeBrun, A Batho, M Macro, S Cheze, O Reman, M Malet, M Leporrier, X Troussard

Malignant vs metabolic bone disease

G Francini